The global Clinical Trials Market has been experiencing significant growth, driven by the escalating demand for innovative drug development and substantial investments in pharmaceutical and biotechnology research. As of 2025, the market size is projected to reach USD 79.7 billion, reflecting a compound annual growth rate (CAGR) of 5.8% over the forecast period. This expansion is propelled by the increasing prevalence of chronic diseases, rapid advancements in precision medicine, and the adoption of decentralized and virtual clinical trials.